17:28 EDT Palisade Bio (PALI) files $300M mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PALI:
- Palisade Bio initiated with an Outperform at Wolfe Research
- Palisade Bio partners with Iterative Health to advance PALI-2108
- Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street
- Palisade Bio announces topline data from PALI-2108 trial
- Palisade Bio initiated with a Buy at H.C. Wainwright
